Feedback (LON:FDBK) Stock Passes Below Two Hundred Day Moving Average – Should You Sell?

Feedback plc (LON:FDBK)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 10.66 and traded as low as GBX 9. Feedback shares last traded at GBX 9, with a volume of 1,214 shares traded.

Feedback Trading Down 1.1%

The company’s 50 day moving average is GBX 11.66 and its 200 day moving average is GBX 10.65. The stock has a market capitalization of £3.94 million, a price-to-earnings ratio of -0.57 and a beta of 0.77.

Feedback (LON:FDBK) last announced its quarterly earnings results on Tuesday, February 17th. The company reported GBX (3.98) EPS for the quarter. Feedback had a negative return on equity of 135.17% and a negative net margin of 845.25%. Analysts anticipate that Feedback plc will post -8 EPS for the current fiscal year.

About Feedback

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.